Article By:
ChinaBio® Today
Saturday, November 28, 2020 12:39 PM EDT
Eluminex Biosciences closed a $50 million Series A Financing from Lilly Asia Ventures, Hillhouse's GL Ventures, and Quan Capital. The company will discover and develop first-in-class that address unmet vision-threatening diseases for global markets.
In this article: GTH